| Financial Year |
March 31 2023 |
| Monetary Funds |
150,681,737.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,332,874.24 |
| Accounts Receivable |
135,810,163.77 |
| Advances to Suppliers |
7,171,934.38 |
| Other Receivables |
16,801,531.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,778,911.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,874,992.81 |
| Total Current Assets |
725,563,792.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,033,913.34 |
| Fixed Assetes |
275,511,421.86 |
| Under-construction Projects |
2,179,900.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,728,441.80 |
| R&D expenses |
-- |
| Goodwill |
20,843,779.10 |
| Long-Term Deferred and Prepaid Expenses |
51,610,663.46 |
| Deferred Income Tax Assets |
23,138,970.40 |
| Other Non-Current Assets |
42,550,917.80 |
| Sub-Total of Non-Current Assets |
455,507,933.84 |
| Total Assets |
1,181,071,726.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,988,214.61 |
| Accounts Payable |
52,758,998.43 |
| Accounts Received In Advance |
18,124.00 |
| Employee Compensation Payable |
13,529,481.87 |
| Taxes Payable |
2,590,233.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,085,394.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
205,536.92 |
| Other Current Liabilities |
4,464,406.64 |
| Sub-Total of Current Liabilities |
157,740,124.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,916,546.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,785,052.13 |
| Total Liabilities |
195,525,176.15 |
| Paid-In Capital(Or Share Stock) |
95,821,700.00 |
| Capital Surplus |
729,551,608.64 |
| Surplus Reserve |
19,141,178.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
123,964,659.98 |
| Minority Stockholder's Interest |
17,067,570.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
968,478,979.68 |
| Owner's Equity（Stockholder's Equity） |
985,546,549.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,181,071,726.04 |
